| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6049034
[patent_doc_number] => 20020169300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Method of detection and treatment of colon cancer by analysis of beta-catenin-sensitive isoforms of lymphoid enhancer factor-1'
[patent_app_type] => new
[patent_app_number] => 10/060844
[patent_app_country] => US
[patent_app_date] => 2002-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5268
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20020169300.pdf
[firstpage_image] =>[orig_patent_app_number] => 10060844
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/060844 | Method of detection and treatment of colon cancer by analysis of beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 | Jan 28, 2002 | Abandoned |
Array
(
[id] => 5986076
[patent_doc_number] => 20020098580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'MDM interacting protein and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/057510
[patent_app_country] => US
[patent_app_date] => 2002-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 26420
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20020098580.pdf
[firstpage_image] =>[orig_patent_app_number] => 10057510
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/057510 | MDM interacting protein and methods of use thereof | Jan 24, 2002 | Abandoned |
Array
(
[id] => 6750293
[patent_doc_number] => 20030044813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Cancer-testis antigens'
[patent_app_type] => new
[patent_app_number] => 10/054683
[patent_app_country] => US
[patent_app_date] => 2002-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 35587
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20030044813.pdf
[firstpage_image] =>[orig_patent_app_number] => 10054683
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/054683 | Cancer-testis antigens | Jan 21, 2002 | Abandoned |
Array
(
[id] => 6715881
[patent_doc_number] => 20030027229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Methods of identifying potentially therapeutically selective and effective anti-cancer agents that are inducers of apoptosis'
[patent_app_type] => new
[patent_app_number] => 10/046548
[patent_app_country] => US
[patent_app_date] => 2002-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10360
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20030027229.pdf
[firstpage_image] =>[orig_patent_app_number] => 10046548
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/046548 | Methods of identifying potentially therapeutically selective and effective anti-cancer agents that are inducers of apoptosis | Jan 15, 2002 | Abandoned |
Array
(
[id] => 679955
[patent_doc_number] => 07084105
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-01
[patent_title] => 'Cytotoxic factors for modulating cell death'
[patent_app_type] => utility
[patent_app_number] => 10/047710
[patent_app_country] => US
[patent_app_date] => 2002-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8688
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/084/07084105.pdf
[firstpage_image] =>[orig_patent_app_number] => 10047710
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/047710 | Cytotoxic factors for modulating cell death | Jan 14, 2002 | Issued |
| 09/936456 | Casb618 polynucleotides and polypeptides and their use | Jan 13, 2002 | Abandoned |
Array
(
[id] => 691443
[patent_doc_number] => 07074902
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-07-11
[patent_title] => 'Antibody specific for a DNA repair protein'
[patent_app_type] => utility
[patent_app_number] => 10/044447
[patent_app_country] => US
[patent_app_date] => 2002-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 31427
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/074/07074902.pdf
[firstpage_image] =>[orig_patent_app_number] => 10044447
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/044447 | Antibody specific for a DNA repair protein | Jan 9, 2002 | Issued |
Array
(
[id] => 938352
[patent_doc_number] => 06972181
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-12-06
[patent_title] => 'Differential diagnosis of cancer and other conditions based on expression of p63'
[patent_app_type] => utility
[patent_app_number] => 10/043502
[patent_app_country] => US
[patent_app_date] => 2002-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9173
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/972/06972181.pdf
[firstpage_image] =>[orig_patent_app_number] => 10043502
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/043502 | Differential diagnosis of cancer and other conditions based on expression of p63 | Jan 8, 2002 | Issued |
Array
(
[id] => 6856679
[patent_doc_number] => 20030130180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Utilization of an aminopeptidase inhibitor'
[patent_app_type] => new
[patent_app_number] => 09/937191
[patent_app_country] => US
[patent_app_date] => 2002-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12788
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20030130180.pdf
[firstpage_image] =>[orig_patent_app_number] => 09937191
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/937191 | Utilization of an aminopeptidase inhibitor | Jan 2, 2002 | Abandoned |
Array
(
[id] => 813580
[patent_doc_number] => 07413870
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-19
[patent_title] => 'SAK: modulation of cellular proliferation for treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/026021
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 20455
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/413/07413870.pdf
[firstpage_image] =>[orig_patent_app_number] => 10026021
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/026021 | SAK: modulation of cellular proliferation for treatment of cancer | Dec 20, 2001 | Issued |
Array
(
[id] => 5858511
[patent_doc_number] => 20020122791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Antigenic CK-18 compounds for therapy and diagnosis and methods for using same'
[patent_app_type] => new
[patent_app_number] => 10/026001
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23484
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20020122791.pdf
[firstpage_image] =>[orig_patent_app_number] => 10026001
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/026001 | Antigenic CK-18 compounds for therapy and diagnosis and methods for using same | Dec 20, 2001 | Abandoned |
| 09/937864 | Methods for detecting cancer cells | Dec 19, 2001 | Abandoned |
Array
(
[id] => 6842938
[patent_doc_number] => 20030148285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Mammalian SIMP protein, gene sequence and uses thereof in cancer therapy'
[patent_app_type] => new
[patent_app_number] => 10/028384
[patent_app_country] => US
[patent_app_date] => 2001-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16121
[patent_no_of_claims] => 83
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20030148285.pdf
[firstpage_image] =>[orig_patent_app_number] => 10028384
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/028384 | Mammalian SIMP protein, gene sequence and uses thereof in cancer therapy | Dec 19, 2001 | Abandoned |
Array
(
[id] => 6797456
[patent_doc_number] => 20030176330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => '55562 and 21617, novel human proteins and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/023617
[patent_app_country] => US
[patent_app_date] => 2001-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 54667
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176330.pdf
[firstpage_image] =>[orig_patent_app_number] => 10023617
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/023617 | 55562 and 21617, novel human proteins and methods of use thereof | Dec 17, 2001 | Abandoned |
Array
(
[id] => 483745
[patent_doc_number] => 07220844
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-22
[patent_title] => 'Liver tumor marker sequences'
[patent_app_type] => utility
[patent_app_number] => 10/017410
[patent_app_country] => US
[patent_app_date] => 2001-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3456
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/220/07220844.pdf
[firstpage_image] =>[orig_patent_app_number] => 10017410
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/017410 | Liver tumor marker sequences | Dec 13, 2001 | Issued |
Array
(
[id] => 6701110
[patent_doc_number] => 20030223990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer'
[patent_app_type] => new
[patent_app_number] => 10/013312
[patent_app_country] => US
[patent_app_date] => 2001-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 109388
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20030223990.pdf
[firstpage_image] =>[orig_patent_app_number] => 10013312
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/013312 | Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer | Dec 6, 2001 | Issued |
Array
(
[id] => 6175900
[patent_doc_number] => 20020155471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => 'Compounds for therapy and diagnosis and methods for using same'
[patent_app_type] => new
[patent_app_number] => 10/017327
[patent_app_country] => US
[patent_app_date] => 2001-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23452
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20020155471.pdf
[firstpage_image] =>[orig_patent_app_number] => 10017327
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/017327 | Compounds for therapy and diagnosis and methods for using same | Dec 5, 2001 | Abandoned |
Array
(
[id] => 679148
[patent_doc_number] => 07083789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-01
[patent_title] => 'Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/006177
[patent_app_country] => US
[patent_app_date] => 2001-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16180
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/083/07083789.pdf
[firstpage_image] =>[orig_patent_app_number] => 10006177
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/006177 | Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer | Dec 3, 2001 | Issued |
Array
(
[id] => 6701629
[patent_doc_number] => 20030224509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'DAP-kinase and HOXA9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer'
[patent_app_type] => new
[patent_app_number] => 10/045400
[patent_app_country] => US
[patent_app_date] => 2001-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7723
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20030224509.pdf
[firstpage_image] =>[orig_patent_app_number] => 10045400
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/045400 | DAP-kinase and HOXA9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer | Nov 28, 2001 | Abandoned |
Array
(
[id] => 132095
[patent_doc_number] => 07700715
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-20
[patent_title] => 'Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 09/996069
[patent_app_country] => US
[patent_app_date] => 2001-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 31203
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/700/07700715.pdf
[firstpage_image] =>[orig_patent_app_number] => 09996069
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/996069 | Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer | Nov 26, 2001 | Issued |